Pilot trial on the effect of the consumption of gold kiwifruit on glycaemic control in individuals with prediabetes

Not Applicable

• Conditions: Prediabetes; Dysglycaemia; Metabolic and Endocrine - Diabetes

• Registration Number: ACTRN12616000858493
• Lead Sponsor: niversity of Otago

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-06-30
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Selection criteria for trial participants will be the requirement to meet the diagnostic criteria for prediabetes according to the American Diabetes Association (ADA) criteria for glycated haemoglobin (HbA1c). All participants will be free living and required to maintain their normal dietary and lifestyle habits for the duration of the trial.
ADA criteria for the diagnosis of prediabetes: HbA1c: 39-46 mmol/mol inclusive.

Exclusion Criteria

a.Individuals unable to give informed consent.
b. Those with an HbA1c outside the range of 39-46 mmol/mol.
c. Those with a previous diagnosis of diabetes.
d. Those on diabetes medications such as Metformin.
e.Those that have taken antibiotics within a month prior to the trial starting.
f.Those with a known kiwifruit allergy.
g.Those with a medical history of significant gastrointestinal disease for example, coeliac disease, inflammatory bowel disease or a previous bowel resection.
h.Women who are pregnant, breastfeeding or planning a pregnancy in the 3 months post selection (trial period) will be excluded.
i.Those who have a planned trip overseas in the 3 months post selection will be excluded.

Study & Design

• Study Type: Interventional
• Study Design: Not specified